Product Information
CYCLOPENTOLATE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $2.6453 per ML under NDC 61314039601. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
61314039601
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CYCLOPENTOLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA084110FDA Approved
Before 1982
TE Code
AT
On Market Since
8/22/2002
Price Statistics
The NADAC for CYCLOPENTOLATE 1% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6453 per ML |
|---|---|
| All-time high | $5.7620 (Jul 14, 2021) |
| All-time low | $1.7840 (Jul 19, 2023) |
| 52-week high | $2.6453 |
| 52-week low | $2.2027 |
| Median price | $4.2668 |
| Average price | $3.8806 |
| Largest weekly change | +72.1% (Aug 23, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclopentolate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOPENTOLATE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOPENTOLATE 1% EYE DROPS, manufactured by Sandoz Inc., is $2.6453 per ML (NDC 61314039601), effective Sep 30, 2026.
How has the price of CYCLOPENTOLATE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for CYCLOPENTOLATE 1% EYE DROPS has declined 52.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYCLOPENTOLATE 1% EYE DROPS?
Since Nov 28, 2013, the NADAC for CYCLOPENTOLATE 1% EYE DROPS has ranged from a low of $1.7840 (Jul 19, 2023) to a high of $5.7620 (Jul 14, 2021), with a median of $4.2668 per ML.
Are there cheaper alternatives to CYCLOPENTOLATE 1% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOPENTOLATE 1% EYE DROPS, is $0.8698 per ML — about 67% below CYCLOPENTOLATE 1% EYE DROPS.
Who manufactures CYCLOPENTOLATE 1% EYE DROPS?
CYCLOPENTOLATE 1% EYE DROPS (NDC 61314039601) is labeled by Sandoz Inc., and CMS classifies it as a generic product.